Search Articles — Sudonull

Search Results

In this project

Data Wall in AI: Deficit Slows Models

https://sudonull.com/data-wall-in-ai-deficit-slows-models

Quality Data Shortage Limits AI Development. Why GPUs Won't Save Us, How Synthetics Fail and Why Real Observations Matter. For Developers: Analysis of Data Wall and Strategies.

T-Technologies: Open Source Strategy in AI/ML and LLM Development

https://sudonull.com/t-technologies-open-source-strategy-in-ai-ml-and-llm-development

How the T-Technologies Group develops open source ecosystems in AI/ML, creating LLMs (T-Pro 2.0, T-One) and tools (Turbo Alignment), as well as investing in research and the community.

Why developers don't trust AI content and code

https://sudonull.com/why-developers-don-t-trust-ai-content-and-code

Study of the reasons for rejection of AI-generated content and code among IT specialists: psychology, information theory, and practical detection markers.

From other projects

5 main fashion trends of May 2026: experts named key trends

https://ymaho.com/5-main-fashion-trends-of-may-2026-experts-named-key-trends

Discover the 5 main fashion trends of May 2026: lace shorts, slide sandals, baseball t-shirts, dark academia, and sporty style. Trend analysis and forecast from experts.

Othman Maama: Why This Football Star Won't Swap Shirts

https://lrivo.com/othman-maama-why-this-football-star-won-t-swap-shirts

Watford's Othman Maama reveals his unique post-match policy of not exchanging shirts due to personal safety concerns. Discover his reasons and what it means for athletes.

T-Beauty in Taiwan: AI Skin Diagnostics and Expansion

https://ymaho.com/t-beauty-in-taiwan-ai-skin-diagnostics-and-expansion

Thailand brings T-Beauty to Taiwan through AI skin analysis and cellular restoration. Learn how data strategy is changing the Asian market. Read the analysis.

Dual-action CAR-T: 100% remission in myeloma at ISCT 2026

https://ymaho.com/dual-action-car-t-100-remission-in-myeloma-at-isct-2026

ISCT 2026 data analysis: CAR-T therapy TPST-2003 showed complete response in all naive patients. Learn why this is a breakthrough, not an illusion, and what risks are hidden.

CAR-T therapy HIV: years of remission after infusion

https://ymaho.com/car-t-therapy-hiv-years-of-remission-after-infusion

DUET-2 data: CAR-T cells keep HIV in remission for over 2 years without ART. Functional cure already a reality? Learn about the breakthrough in HIV treatment.

CAR-T therapy for lupus: FDA approval 2026

https://ymaho.com/car-t-therapy-for-lupus-fda-approval-2026

Analysis of FDA approval of the first CAR-T cell therapy for severe lupus. Key players, forecasts, and hidden risks. Find out who is leading the race.

Trending Now